News

CLINUVEL
Posted by CLINUVEL
September 20, 2023

Appendix 3Y - Change of Director’s Interest Notice

CLINUVEL has entered a formal collaboration with four of the world’s leading...

Read More
CLINUVEL
Posted by CLINUVEL
September 19, 2023

CEO letter to shareholders

Melbourne, Australia, 19 September 2023 ASX: CUV Frankfurt Börse: UR9 Level 1...

Read More
CLINUVEL
Posted by CLINUVEL
September 13, 2023

CLINUVEL Confirms AGM Date

Melbourne, Australia, 13 September 2023 ASX: CUV Frankfurt Börse: UR9 Level 1...

Read More
CLINUVEL
Posted by CLINUVEL
September 12, 2023

CLINUVEL Vitiligo Expert Panel

CLINUVEL has entered a formal collaboration with four of the world’s leading...

Read More
CLINUVEL
Posted by CLINUVEL
September 5, 2023

SCENESSE® in adolescent EPP study

Melbourne, Australia, 5 September 2023 ASX: CUV Frankfurt Börse: UR9 Level 1...

Read More
CLINUVEL
Posted by CLINUVEL
August 30, 2023

Investor Webinar transcript

Melbourne, Australia, 30 August 2023 ASX: CUV Frankfurt Börse: UR9 Level 1...

Read More
CLINUVEL
Posted by CLINUVEL
August 29, 2023

Appendix 4G and Corporate Governance Statement

Melbourne, Australia, 29 August 2023 ASX: CUV Börse Frankfurt: UR9 Level 1...

Read More
CLINUVEL
Posted by CLINUVEL
August 29, 2023

CLINUVEL delivering on a long-term strategy with increase in annual revenues, profit

Melbourne, Australia, 29 August 2023 ASX: CUV XETRA-DAX: UR9 Level 1 ADR:...

Read More
CLINUVEL
Posted by CLINUVEL
August 29, 2023

Dividend/Distribution – CUV

Melbourne, Australia, 29 August 2023 ASX: CUV Börse Frankfurt: UR9 Level 1...

Read More
CLINUVEL
Posted by CLINUVEL
August 29, 2023

Appendix 4E & Annual Report

Melbourne, Australia, 29 August 2023 ASX: CUV Börse Frankfurt: UR9 Level 1...

Read More